These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 18040647)
1. Effects on kidney disease, fertility and development in mice inheriting a protein-truncating Denys-Drash syndrome allele (Wt1tmT396). Patek CE; Brownstein DG; Fleming S; Wroe C; Rose L; Webb A; Berry RL; Devenney PS; Walker M; Maddocks OD; Lawrence NJ; Harrison DJ; Wood KM; Miles CG; Hooper ML Transgenic Res; 2008 Jun; 17(3):459-75. PubMed ID: 18040647 [TBL] [Abstract][Full Text] [Related]
2. Murine Denys-Drash syndrome: evidence of podocyte de-differentiation and systemic mediation of glomerulosclerosis. Patek CE; Fleming S; Miles CG; Bellamy CO; Ladomery M; Spraggon L; Mullins J; Hastie ND; Hooper ML Hum Mol Genet; 2003 Sep; 12(18):2379-94. PubMed ID: 12915483 [TBL] [Abstract][Full Text] [Related]
3. A zinc finger truncation of murine WT1 results in the characteristic urogenital abnormalities of Denys-Drash syndrome. Patek CE; Little MH; Fleming S; Miles C; Charlieu JP; Clarke AR; Miyagawa K; Christie S; Doig J; Harrison DJ; Porteous DJ; Brookes AJ; Hooper ML; Hastie ND Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2931-6. PubMed ID: 10077614 [TBL] [Abstract][Full Text] [Related]
4. A novel WT1 heterozygous nonsense mutation (p.K248X) causing a mild and slightly progressive nephropathy in a 46,XY patient with Denys-Drash syndrome. da Silva TE; Nishi MY; Costa EM; Martin RM; Carvalho FM; Mendonca BB; Domenice S Pediatr Nephrol; 2011 Aug; 26(8):1311-5. PubMed ID: 21559934 [TBL] [Abstract][Full Text] [Related]
5. Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1. Borel F; Barilla KC; Hamilton TB; Iskandar M; Romaniuk PJ Biochemistry; 1996 Sep; 35(37):12070-6. PubMed ID: 8810912 [TBL] [Abstract][Full Text] [Related]
6. Focal Segmental Membranoproliferative Glomerulonephritis: A Histological Variant of Denys-Drash Syndrome. Karmila AB; Yap YC; Appadurai M; Oh L; Fazarina M; Abd Ghani F; Ariffin H Fetal Pediatr Pathol; 2021 Apr; 40(2):113-120. PubMed ID: 31707902 [No Abstract] [Full Text] [Related]
7. The Wt1+/R394W mouse displays glomerulosclerosis and early-onset renal failure characteristic of human Denys-Drash syndrome. Gao F; Maiti S; Sun G; Ordonez NG; Udtha M; Deng JM; Behringer RR; Huff V Mol Cell Biol; 2004 Nov; 24(22):9899-910. PubMed ID: 15509792 [TBL] [Abstract][Full Text] [Related]
8. A novel WT1 gene mutation in a newborn infant diagnosed with Denys-Drash syndrome. Hakan N; Aydin M; Erdogan O; Cavusoglu YH; Aycan Z; Ozaltin F; Zenciroglu A; Apaydin S; Gunes R; Sahin G; Cinar G; Okumus N Genet Couns; 2012; 23(2):255-61. PubMed ID: 22876585 [TBL] [Abstract][Full Text] [Related]
9. Clinical pictures and novel mutations of WT1-associated Denys-Drash syndrome in two Chinese children. Yue Z; Pei Y; Sun L; Huang W; Huang H; Hu B; Yang J; Jiang X; Mo Y; Chen S; Lai KN; Wang Y Ren Fail; 2011; 33(9):910-4. PubMed ID: 21851196 [TBL] [Abstract][Full Text] [Related]
10. WT1 Haploinsufficiency Supports Milder Renal Manifestation in Two Patients with Denys-Drash Syndrome. Guaragna MS; Ribeiro de Andrade JG; de Freitas Carli B; Belangero VM; Maciel-Guerra AT; Guerra-Júnior G; de Mello MP Sex Dev; 2017; 11(1):34-39. PubMed ID: 28081536 [TBL] [Abstract][Full Text] [Related]